In this week’s Patent News – CPI(M) asks Government to issue compulsory license for manufacturing generic versions of drug – Remdesivir; EPO creates search strategies to aid scientists distinguish documents relevant to fight the COVID-19 pandemic; EUIPO and EPO to jointly host online conference on Additive Manufacturing
INDIA PATENT NEWS UPDATE
CPI(M) asks Government to issue compulsory license for manufacturing generic versions of drug - Remdesivir
The Communist Party of India (Marxist) has reportedly requested the Central…
Mr. Gaurav Mishra, Managing Associate at BananaIP Counsels delivered a talk on the Compulsory licensing provisions in India under the Patents Act on the 3rd of June 2020 at an event organized by the Department of Science and technology, Rajasthan. The webinar event was attended by over a 100 participants including, students, lawyers, medical professionals and academicians. The talk was delivered as part of the Rajasthan, DST's laudable initiative of creating IP awareness as well as helping the attendees grasp…